Table 4 |
||
|
Drugs approved by the Food and Drugs Administration for treatment of fibromyalgia |
||
|
Drug |
Class |
Mechanism |
|
|
||
|
Duloxetine |
Antidepressant |
Balanced norepinephrine and serotonin reuptake inhibition |
|
Milnacipran |
Antidepressant |
Balanced norepinephrine and serotonin reuptake inhibition |
|
Pregabalin |
Anticonvulsant |
α2δ ligand; affects calcium influx and release of excitatory amino acids and neuropeptides |
|
|
||
|
Buskila Arthritis Research & Therapy 2009 11:242 doi:10.1186/ar2720 |
||